Friday, August 3, 2007 - Page updated at 02:05 AM
E-mail article
Print view Share:
Digg
Newsvine
Biotech incubator raises $22.5M
Seattle Times business reporter

Carl Weissman, chief executive of Accelerator biotech incubator
Accelerator, Seattle's souped-up biotech incubator, has raised $22.5 million in its third and largest investment round. The funds will help start up to six emerging companies over the next two or three years, said Chief Executive Carl Weissman.
Accelerator operates as a kind of biotech nursery — it channels money from venture-capital firms into early stage start-ups, and closely manages them until they raise enough money to stand on their own or are deemed a failure. The incubator also provides office space for the fledglings in its Eastlake headquarters.
The budding companies are under strict supervision, meeting with the Accelerator team to discuss milestones once a week, said Weissman.
Since its 2003 founding, Accelerator has invested in six companies, two of which — VLST and Spaltudaq — gained independence after raising some $84 million in venture capital. One company was cut off after failing to develop a feasible strategy, Weissman said.
When a company succeeds in leaving the nest, "it's a pleasure to hand off the keys," Weissman said. He expects further graduations next year.
Accelerator's role in the Seattle biotech community is heightened by the relative lack of local venture-capital firms devoted to investing in the life sciences, compared with thriving hubs such as Boston or San Francisco. Companies here "have to work harder" to raise money, said Jack Faris, president of the Washington Biotechnology and Biomedical Association.
"Some of the most exciting startups launched here within the past couple of years have been with the Accelerator," Faris said. "It's a terrific asset."
Entrepreneurs aching for admission, however, would have more chance of getting into an Ivy League school. Since its inception, Accelerator has received more than 400 proposals and chosen only six, said Weissman.
Most participants in the latest funding round are repeat customers: Amgen Ventures, Arch Venture Partners, OVP Venture Partners and Alexandria Real Estate Equities. But there's also a new investor: WRF Capital, an arm of the Washington Research Foundation.
The high-profile Institute for Systems Biology continues to be the "key scientific institutional anchor" for Accelerator, a statement from the incubator said. The institute's faculty has provided or helped select the technology used in more than half of Accelerator's start-ups, said ISB Director Leroy Hood in the statement.
Ángel González: 206-515-5644
Copyright © 2007 The Seattle Times Company

Enjoy 3 courses for $30, May 1-29
Dine at 23 new Seattle-area restaurants.
New Urban Eats, a dining event from NWsource.
View participating restaurants
Enter to win dinner for two
- Clinton advisers talk exit strategy | Election 2008
- Hankering for a patty in a bun? Hit these local burger joints
- He's a King County foreclosure man: "I'm the bearer of bad news"
- Bicyclist on I-5 causes traffic jam
- M's go down with a fight in 5-0 loss to Texas
- Aid is on the way to devastated Myanmar but so is heavy rain
- Southcenter mall expansion to open July 25
- Shake-up at Seattle Schools
- Mariah Carey, Nick Cannon wed | Odds and Ends
- 19-year-old man sentenced to life in prison for murder of taxi driver
- Hankering for a patty in a bun? Hit these local burger joints
- In autistic boy's hands, paper and scissors express an amazing spectrum
- Hispanic students at Interlake pull together to graduate
- He's a King County foreclosure man: "I'm the bearer of bad news"
- Southcenter mall expansion to open July 25
- Love bread? Then you need to try this easy recipe | Nancy Leson
- Put your UW devotion into words . . . for $1,000
- Landscaping with the ultimate guy toy — a flamethrower | Trail Mix | Ron Judd
- Bicyclist on I-5 causes traffic jam
- Shake-up at Seattle Schools

